Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY LDP Begins Intraparty Deliberations on Economic, Fiscal Blueprint
June 24, 2015
-
REGULATORY 80% Generic Share “at Early Date,” Essential Drug Supplies Join Draft Fiscal Policy Blueprint
June 23, 2015
-
REGULATORY AMED’s Screening Consortium “Won’t Harm Companies”: Official
June 22, 2015
-
BUSINESS 30 Companies Obtain Listing for Plavix Generics
June 19, 2015
-
REGULATORY Ryukaikon to Push Single-Product, Single-Price Deals in New Proposal Due Out Summer
June 18, 2015
-
REGULATORY Govt Deregulation Panel Calls for Revisiting 14-Day Prescription Limit
June 17, 2015
-
ACADEMIA MHLW Official Restates Difficulty of Moving Up Timeline to Attain 80% Generic Share
June 16, 2015
-
ORGANIZATION Industry Calls for Definition of “Basic Drugs”: FPMAJ Committee
June 15, 2015
-
REGULATORY Takeda Slapped with Business Improvement Order over CASE-J
June 12, 2015
-
REGULATORY Accession Requirements for ICH Assembly Hammered Out at Fukuoka Confab
June 12, 2015
-
ORGANIZATION EFPIA Japan Chief Frets Negative Market Growth amid Pressure on Drug Costs
June 11, 2015
-
BUSINESS Novartis Japan Chief Vows All-Out Effort to Regain Trust
June 10, 2015
-
BUSINESS Highlights of FY2014 Earnings - Part 5: Lackluster 1% Sales Growth Likely in FY2015
June 10, 2015
-
REGULATORY LDP Eyes Filing of 15 Sakigake Designated Products by FY2018
June 9, 2015
-
ORGANIZATION Industry, Govt, Academia Should Discuss Challenges Facing Biosimilars: Prof. Kurokawa
June 9, 2015
-
BUSINESS Highlights of FY2014 Earnings - Part 4: Overseas Sales Top 4 Trillion Yen; Fate of Drug Makers Will Depend on New Global Products
June 9, 2015
-
REGULATORY Roughly 60 Products Submitted as Candidates for Review under Sakigake Designation System
June 8, 2015
-
BUSINESS Highlights of FY2014 Earnings - Part 3: New Cancer Drugs Off to Strong Start
June 8, 2015
-
BUSINESS Lilly Japan Plans Excursion to Local Cities in Quest for Novel Drug Seeds
June 5, 2015
-
BUSINESS Highlights of FY2014 Earnings - Part 2: Sales of 42 Major Long-Listed Products Sag Nearly 20%
June 5, 2015
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…